BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12060528)

  • 1. Effect of Misgurnus anguillicaudatus polysaccharide on immune responses of splenocytes in mice.
    Qin CG; Huang KX; Xu HB
    Acta Pharmacol Sin; 2002 Jun; 23(6):534-8. PubMed ID: 12060528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ganoderma lucidum polysaccharides enhance the function of immunological effector cells in immunosuppressed mice.
    Zhu XL; Chen AF; Lin ZB
    J Ethnopharmacol; 2007 May; 111(2):219-26. PubMed ID: 17182202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Phytolacca acinosa polysaccharides I on immune function in mice.
    Wang HB; Zheng QY; Qian DH; Fang J; Ju DW
    Zhongguo Yao Li Xue Bao; 1993 May; 14(3):243-6. PubMed ID: 8237401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of anticonvulsants on cellular immunity].
    Okamoto Y; Shimizu K; Tamura K; Yamada M; Matsui Y; Hayakawa T; Mogami H
    No To Shinkei; 1989 Mar; 41(3):299-304. PubMed ID: 2503016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of alloimmune cytotoxic T lymphocyte (CTL) generation by depletion of NK cells and restoration by interferon and/or interleukin 2.
    Suzuki R; Suzuki S; Ebina N; Kumagai K
    J Immunol; 1985 Apr; 134(4):2139-48. PubMed ID: 2579129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the mechanisms of action of the immunomodulator Bestatin in various screening test systems.
    Schorlemmer HU; Bosslet K; Dickneite G; Lüben G; Sedlacek HH
    Behring Inst Mitt; 1984 May; (74):157-73. PubMed ID: 6383322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
    Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of suppressed natural killer cell activity with altered host resistance models in B6C3F1 mice.
    Wilson SD; McCay JA; Butterworth LF; Munson AE; White KL
    Toxicol Appl Pharmacol; 2001 Dec; 177(3):208-18. PubMed ID: 11749120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphokine-activated killer (LAK) cells. I. Differential recovery of LAK, natural killer cells, and cytotoxic T lymphocytes after a sublethal dose of cyclophosphamide.
    Ballas ZK
    J Immunol; 1986 Oct; 137(7):2380-4. PubMed ID: 3489763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
    Brunda MJ; Taramelli D; Holden HT; Varesio L
    J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of phenytoin on cell-mediated immunity].
    Okamoto Y; Shimizu K; Tamura K; Miyao Y; Yamada M; Matsui Y; Tsuda N; Mogami H
    No To Shinkei; 1987 Oct; 39(10):931-6. PubMed ID: 3501727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic administration of recombinant interleukin-6 in mice induces proliferation of lymphoid cells in vivo.
    Puri RK; Leland P
    Lymphokine Cytokine Res; 1992 Jun; 11(3):133-9. PubMed ID: 1391232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of F1 cytotoxic potentials by GvHR. Host- and donor-derived cytotoxic lymphocytes arise in the unirradiated F1 host spleens under the condition of GvHR-associated immunosuppression.
    Kubota E; Ishikawa H; Saito K
    J Immunol; 1983 Sep; 131(3):1142-8. PubMed ID: 6604089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
    Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and activity of dipeptides, linked to targeting ligands, as specific NK cell enhancers.
    Abbott SD; Gagnon L; Lagraoui M; Kadhim S; Attardo G; Zacharie B; Penney CL
    J Med Chem; 1998 May; 41(11):1909-26. PubMed ID: 9599240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in target cell DNA fragmentation induced by mouse cytotoxic T lymphocytes and natural killer cells.
    Duke RC; Cohen JJ; Chervenak R
    J Immunol; 1986 Sep; 137(5):1442-7. PubMed ID: 2943792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inhibitory effects of pravastatin on natural killer cell activity in vivo and on cytotoxic T lymphocyte activity in vitro.
    Katznelson S; Wang XM; Chia D; Ozawa M; Zhong HP; Hirata M; Terasaki PI; Kobashigawa JA
    J Heart Lung Transplant; 1998 Apr; 17(4):335-40. PubMed ID: 9588577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of the synthetic preparation B 58 on the activity of natural killer and cytostatic cells of the mouse spleen].
    Malaĭtsev VV; Bogdanova IM; Spivak NIa; Bogdashin IV; Zueva VS
    Biull Eksp Biol Med; 1987 Jun; 103(6):697-9. PubMed ID: 2439142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of methionine enkephalin on natural killer cell and cytotoxic T lymphocyte activity in mice infected with influenza A virus.
    Burger RA; Warren RP; Huffman JH; Sidwell RW
    Immunopharmacol Immunotoxicol; 1995 May; 17(2):323-34. PubMed ID: 7650294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo modulation of thymus-derived lymphocytes with monoclonal antibodies in mice. II. Separation of natural killer cells and cytotoxic T cells.
    Le Gros GS; Herbert AG; Watson JD
    Immunology; 1984 Jan; 51(1):103-13. PubMed ID: 6606615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.